0001062993-22-015725.txt : 20220701
0001062993-22-015725.hdr.sgml : 20220701
20220701160117
ACCESSION NUMBER: 0001062993-22-015725
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220630
FILED AS OF DATE: 20220701
DATE AS OF CHANGE: 20220701
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Potter Stephen W
CENTRAL INDEX KEY: 0001511991
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36370
FILM NUMBER: 221061319
MAIL ADDRESS:
STREET 1: 7015 ALBERT EINSTEIN DR
CITY: COLUMBIA
STATE: MD
ZIP: 21046
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: APPLIED GENETIC TECHNOLOGIES CORP
CENTRAL INDEX KEY: 0001273636
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 593553710
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: 14193 NW 119TH TERRACE
STREET 2: SUITE #10
CITY: ALACHUA
STATE: FL
ZIP: 32615
BUSINESS PHONE: 386-462-2204
MAIL ADDRESS:
STREET 1: 14193 NW 119TH TERRACE
STREET 2: SUITE #10
CITY: ALACHUA
STATE: FL
ZIP: 32615
4
1
form4.xml
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
X0306
4
2022-06-30
0001273636
APPLIED GENETIC TECHNOLOGIES CORP
AGTC
0001511991
Potter Stephen W
C/O APPLIED GENETIC TECHNOLOGIES CORP.
14193 NW 119TH TERRACE, SUITE #10
ALACHUA
FL
32615
0
1
0
0
Chief Business Officer
Common Stock
2022-07-01
4
S
0
8070
0.7745
D
55883
D
The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of 26,250 shares underlying 35,000 restricted stock units ("RSUs") granted under the Applied Genetic Technologies Corporation ("AGTC") 2013 Equity and Incentive Plan on June 17, 2021. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $0.7700 to $0.7793, inclusive. The Reporting Person undertakes to provide to the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range(s) set forth in this footnote of this Form 4.
Includes the remaining 8,750 RSUs subject to vesting on December 31, 2022.
/s/ Stacie Aarestad, Attorney-in-fact
2022-07-01